Skip to main content
Day.News — Local News. Real Community.
JASPER DAY NEWS
Local News. Real Community.

National

09/15/2026 · Jasper

Full Edition

FDA Approves New Pancreatic Cancer Drug Rasonque

The U.S. Food and Drug Administration approved Rasonque, a RAS inhibitor, for advanced pancreatic cancer. This decision provides a new treatment option for patients earlier than anticipated.

09/13/2026
Read Story
Health

FDA Authorizes First Device to Continuously Monitor Glucose and Ketones

The U.S. Food and Drug Administration has authorized the first wearable device that continuously monitors both ketone levels and blood sugar. The Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System received approval for use by individuals aged two years and older living with diabetes.

09/13/2026

Politics

U.S. Imposes Sanctions on Organizations Designated as Threatening National Security

The United States has enacted sanctions against several organizations, including Autistici/Inventati, citing their alleged roles in providing support for or engaging in acts of violence. The measures block all U.S.-jurisdiction property and interests of the designated entities.

09/13/2026

Education

Consumers Face Compounding Financial Pressures Amid Rising Costs

Households already carrying debt now confront a new series of financial challenges. These include increased costs for back-to-school items, potential expenses from hurricane season, and ongoing essential pet care.

09/13/2026

Politics

U.S. Secretary Rubio Addresses ASEAN Conference, Discusses Iran and Regional Investments

Secretary of State Marco Rubio reiterated U.S. commitment to the ASEAN region at a conference in Manila. He announced $2.5 billion in U.S. government strategic investments and addressed the situation in the Middle East, specifically regarding Iran and the Strait of Hormuz.

09/11/2026

Entertainment

FDA Approves Viral Immunotherapy for Advanced Melanoma

The U.S. Food and Drug Administration granted accelerated approval to Tudriqev, a new viral immunotherapy. The treatment is for advanced melanoma that has not responded to other therapies. This genetically modified oncolytic virus represents a new option for patients.

09/11/2026

Sponsored

Advertisement

Local Venues

View all

Advertisement

Advertisement

Upcoming Events

View all

SEP

19

Houston at Texas Tech

00:00

SEP

19

North Texas at Texas St.

16:00

SEP

19

SMU at Louisville

19:30

Announcements

View all
!

Community

Community Government Websites by CivicPlus® Create a Website Account - Manage notification subscriptions, save form progress and more. Website Sign In Home Community Community Government Websites by CivicPlus® Loading Loading Do Not Show Again Close Arrow Left Arrow Right [] Slideshow Left Arrow Slideshow Right Arrow

!

Website Sign In

Sign In - Authentication Sign In for TX-VanHorn Don't have an account? Sign up Email Password Forgot your password? Remember me Sign In Continue Or sign in using Sign in with Apple Sign in with Facebook Sign in with Google Sign in with Microsoft (PERSONAL) View Additional Options By signing in, you agree to our Terms of Service and Privacy Policy.

!

Create a Website Account

Create a New Account - Authentication Create a New Account for TX-VanHorn Your account will be managed by an external identity provider. Your password will be managed by an external identity provider. You will need to contact your IT Administrator to change your settings. Email First Name Last Name Single Sign On is enabled for your account Your password must be at least 8 characters in length and contain characters from both of the following categories: English characters (a through Z) Base 10 digits (0 through 9) Password Confirm Password This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. By signing in, you agree to our Terms of Service and Privacy Policy. Create Account Already have an account? Sign in OR Use Another Service to Create an Account Sign up with Apple Sign up with Facebook Sign up with Google Sign up with Microsoft (PERSONAL)

Advertisement

Advertisement

Advertisement

Advertisement